Advance Access and Delivery Inc

“Financial reports and the form 990 are reviewed by the organization's executive director and board of directors for approval.”

“Each director, principal officer and member of a committee with governing board delegated powers annually signs a statement affirming they have received a copy of the policy, read and understand the policy, agreed to comply with the policy and understands the organization must engage primarily in activities that accomplish one or more of its tax-exempt purposes in order to maintain their federal tax exemption.”

“Reasonable compensation policies have been established based on collaboration of the board of directors, reliance on professional experience, and comparison to other similar organizations.”

“Reasonable compensation policies have been established based on the experience of the board of directors, ceo, such that employee pay and benefits are comprable to similar organizations and within market range.”

“Governing documents, disclosure explanation, articles of incorporation, by-laws, conflict of interest policy and other governing policies and 990's are on file and available on the organization's website and upon request.”

“To work in solidarity with partners around the world to overcome barriers to high quality health care and medicines, particularly for economically and socially marginalized groups. This means supporting coalitions around the world doing this work, but also working to break down double standards that persist in global health care policy.”

“Zero tb initiative - supports cities, districts, and islands that are committed to achieving a rapid reduction in the number of people suffering from tb. Multidisease platform - working to design a patient and community centered global health delivery platform that screens for, provides care for, and monitors multiple diseases at once to provide more comprehensive care to individuals. Diseases include tuberculosis, hepatitis, hiv, and diabetes. Mapping - the tb drug access atlas is a data driven tool developed through rigorous methods to understand activities of key stakeholders who are operating in the iqa sld landscape to address the burden of mdr-tb. This tool is meant to inform decision-making, understanding programmatic overlaps, and take advantage of shared strengths, with the goal to encourage dialogue and spur movement toward getting patients the drugs they need.”